iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)

MBL Life Sciences

Catalog No.:
MBL-TS-0017-2
iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)
Shipping:
Calculated at Checkout
$1,575.00
Formerly Catalog No.: TB-0017-2
Adding to cart… The item has been added

Related Products

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications
Application FC
Reactivity Human
Conjugation APC
Peptide Sequence VLQELNVTV
Class Class I
Sequence Location 169-177
MHC Allele A*02:01

Documents & Links for iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)
Datasheet iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV) Datasheet

Documents & Links for iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)
Datasheet iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV) Datasheet
Citations for iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV) – 1 Found
Morita, Yuriko; Heike, Yuji; Kawakami, Mami; Miura, Osamu; Nakatsuka, Shin-Ichi; Ebisawa, Michiko; Mori, Shin-Ichiro; Tanosaki, Ryuji; Fukuda, Takahiro; Kim, Sung-Won; Tobinai, Kensei; Takaue, Yoichi. Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation. International Journal Of Cancer. 2006;119(6):1360-7.  PubMed
!